PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis
Abstract
Authors
F. Buckley S. Ogale F. Dejonckheere J.P. Jansen